• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • MANUFACTURERS
  • HEADHUNTERS
  • COMPANIES

SPINEMarketGroup

Spine Industry News

  • HOME
  • 2026
  • 2025
  • 2024
  • BROCHURES
  • ARTICLES
  • PRODUCT LIBRARY

Globus in takeover talks with NuVasive to boost spine portfolio

November 17, 2021 By SPINEMarketGroup

The J.P.Morgan analysts see “significant challenges” to the potential acquisition of NuVasive because of the nature of the spine market. Globus will need to weigh whether the potential dis-synergies offset the chance to cut costs.

“It’s worth reiterating that ‘one + one’ rarely gets to ‘two’ on the top line, with significant portfolio overlap often coupled with overlapping customers and salesforces. The flip side of this does come on the cost-front, as eliminating this overlap can often lead to meaningful synergy capture even as the top line suffers in this highly rep-intensive business model,” the analysts wrote in a note to investors.

The analysts cited J&J’s takeover of Synthes in 2012, Zimmer’s buyouts of Biomet and LDR in 2015 and 2016, respectively, and Stryker’s 2018 acquisition of K2M as examples of how hard it is to make spine deals work. As the analysts see things, J&J “failed to stem share loss” while Zimmer is suffering “continued declines several years out still” and Stryker had a tough first year despite its integration expertise.

However, could a Globus-NuVasive merger buck the trend? J.P. Morgan analysts highlighted NuVasive’s differentiated technologies, such as its X360 anterior procedural solutions, as examples of how it may bring value to Globus. Yet, the analysts also see “significant overlap in the core implant portfolio as well as on the navigation and robotics sides.”

Globus cited its ExcelsiusGPS robot as the driver of the growth of its enabling technology unit, which posted a 124% jump in sales in the third quarter. NuVasive has its own Pulse robotic system.

While J&J has multiple robotic systems, the J.P.Morgan analysts have doubts about whether “it makes sense for Globus to support a platform that overlaps so much with its existing one.”

Truist analysts also see the deal as unlikely given that large integrations can be messy.

“While we see NuVasive possessing valuable assets, Globus has demonstrated it can successfully grow and gain share organically, and we think an integration of that size could distract from that growth formula,” the analysts wrote.

Investors appear to share some of the concerns. Shares in Globus fell 4% in the wake of the reports, shaving a little off the top of its $7 billion-plus market cap. NuVasive’s stock went in the opposite direction, rising 5% to push its market cap up above $3 billion.

SOURCE:https://www.medtechdive.com

Related Posts:

  • Globus Medical acquires Nuvasive: Our first thoughts…
  • Globus Medical slide continues after a raft of…
  • What could be the consequences of the fusion of…

Filed Under: NEWS Tagged With: 2021, NEWS

Primary Sidebar

PLATINUM SPONSORS

EXALTA 2LOGO-min
GLOBAL biomedica
NORMED newLOGO-min
GENESYS SPINE
SPINEGUARD2025
Dymicron 2
GSMEDICAL2025
spinewaygroup
RUTHLESS SPINE
RUDISHAUER
NGMEDICAL
LfC
ispine
CENTINEL SPINE
TSUNAMI MEDICAL
syntropiq logo
A-SPINE
L&Kmodelo log

POPULAR POST LAST 90 DAYS

  • Globus Medical and Synaptive: Why the Rumors Deserve…
  • What Globus Medical Really Bought With Higgs Boson Health
  • BROCHURES
  • Globus Medical Announces Acquisition of Higgs Boson…
  • Neck and Neck: Is Globus Finally About to Overtake…
  • Who Runs DePuy Synthes? The CEO Fight That Killed…
  • Globus Medical to Showcase SCRIPT™ Patient-Specific…
  • J&J’s $21B DePuy Synthes Bet Could End in…
  • Federal Circuit Backs Globus Medical in Spinal…
  • Centinel Spine Files for NYSE IPO After 42% Jump in…
  • COMPANIES
  • Do Spine Companies Really Need So Many Implants?…
  • Record Earnings, Discount Valuation: What Globus…
  • DePuy Synthes for Sale: Who Could Actually Buy the…
  • Globus Medical Reports Third Quarter 2026 Results…
  • New CFO, New AI Chief and a Patent Fight: What Is…
  • (UPDATED 2026) More Than 100 Options, No Single…
  • CD HORIZON® SOLERA™ System
  • 3D-Printed Cages Are Everywhere. Has the Technology…
  • Top Expandable Cages of 2025: Which Lumbar Implants…
  • (UPDATED 2025): 6 Artificial Cervical Discs You’ll…
  • Globus Medical Acquires Synaptive Medical,…
  • What Is a Spine Hub, and Why Did Avesi Invest in New…
  • SYMPHONY Occipito-Cervico-Thoracic (OCT) System
  • Whatever Happened to the Translational Cervical…
  • Forty Cervical Discs, One 3% Market: The Fight to…
  • FDA clears Solco’s Blue Dolphin cage for minimally…
  • Carlsmed Launches aprevo® Lumbar Bi-lateral Posterior System
  • Thinking About a Spine Robot? Your 2026 Guide to the…
  • Carlsmed, Inc. Files Patent Infringement Lawsuit…
  • LAST 5 VIDEOS PUBLISHED

    1. GS Medical: QUASAR™ Stand-Alone ACIF
    2. SI-BONE: iFuse Granite Onyx™
    3. NovaSpine: DIVA Cervical
    4. Xenix Medical: Riva Modular Fixation System
    5. Spinal Elements: Overwatch® PCF

    Footer

    Contact us:

    spinemarketgroup@gmail.com info@thespinemarketgroup.com

    • LinkedIn
    • Twitter
    • YouTube

    PRIVACY POLICY

    • Legal
    • PRODUCT LIBRARY

    Copyright © 2026 · SPINEMarketGroup